Phenylbutazone Boluses
» Phenylbutazone Boluses contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of phenylbutazone (C19H20N2O2) and nominally not less than 1 g of phenylbutazone per bolus.
Packaging and storage— Preserve in well-closed containers.
Labeling— Label Boluses to indicate that they are for veterinary use only.
A: Transfer a portion of powdered Boluses, equivalent to about 500 mg of phenylbutazone, to a 250-mL conical flask, add 100 mL of solvent hexane, and heat the mixture under reflux for 15 minutes. Filter the hot mixture, and allow the filtrate to cool. Separate the crystals thus formed by filtration, and dry in vacuum at 80 for 30 minutes: the phenylbutazone so obtained responds to Identification test A under Phenylbutazone.
B: The retention time of the phenylbutazone peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Disintegration 701: 45 minutes with disks, determined as directed for Uncoated Tablets, simulated gastric fluid being used as the immersion fluid.
Uniformity of dosage units 905 meet the requirements for Weight Variation.
Acetate buffer, Mobile phase, Internal standard solution, Standard preparation, and Chromatographic system Proceed as directed in the Assay under Phenylbutazone.
Assay preparation— Weigh and finely powder a Phenylbutazone Bolus. Transfer an accurately weighed portion of the powder, equivalent to about 500 mg of phenylbutazone, to a 250-mL volumetric flask. Transfer 10.0 mL of water to the flask, and shake by mechanical means for 15 minutes. Add about 120 mL of acetonitrile, and sonicate until insoluble material is dispersed into fine particles. Shake by mechanical means for 20 minutes, dilute with acetonitrile to volume, and mix. Transfer 7.0 mL of this solution to a 50-mL volumetric flask, add 10.0 mL of Internal standard solution, dilute with acetonitrile to volume, and mix. Pass a portion of this solution through a filter having a porosity of 0.5 µm or finer, discarding the first few mL of the filtrate. Use the clear filtrate as the Assay preparation. [note—Use this solution within 8 hours of its preparation.]
Procedure— Proceed as directed for Procedure in the Assay under Phenylbutazone. Calculate the quantity, in mg, of C19H20N2O2 in the portion of the Bolus taken by the formula:
1786C (RU / RS)
in which C is the concentration, in mg per mL, of USP Phenylbutazone RS in the Standard preparation, and RU and RS are the ratios of the peak responses of phenylbutazone to that of the internal standard obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Ian DeVeau, Ph.D.
Director, Veterinary Drugs and Radiopharmaceuticals
(VET05) Veterinary Drugs 05
Reference Standards Lili Wang, Technical Services Scientist
701 Margareth R.C. Marques, Ph.D.
Senior Scientist
(BPC05) Biopharmaceutics05
USP32–NF27 Page 3281
Pharmacopeial Forum: Volume No. 33(1) Page 82
Chromatographic Column—
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.